Related Experiment Videos
Fears about breast cancer recurrence:
1Department of Social-Personality Psychology, The Graduate Center, City University of New York, USA.
Cancer Practice
|March 7, 2002
Summary
Most breast cancer survivors experience moderate fears of recurrence, focusing on death, treatment, and family impact. Understanding these fears and life context is crucial for effective support.
Area of Science:
- Oncology
- Psychology
- Cancer Survivorship
Background:
- Majority of breast cancer survivors report persistent fears of recurrence.
- Previous research often quantifies fear using Likert scales, lacking experiential depth.
- Limited understanding of the qualitative nature and nuances of these fears.
Purpose of the Study:
- To explore and describe the diverse experiences and nature of breast cancer recurrence fears in women.
- To capture qualitative data on women's thoughts and feelings about potential recurrence.
- To provide a foundation for more in-depth investigations into cancer recurrence anxiety.
Main Methods:
- Conducted semi-structured interviews with 16 women diagnosed with breast cancer.
- Explored participants' thoughts, feelings, and experiences related to the possibility of recurrence.
- Employed thematic content coding to analyze qualitative interview data.
Main Results:
- While some women expressed strong fears, most reported moderate levels of recurrence anxiety.
- Fears encompassed themes of mortality, further treatment (chemotherapy), emotional distress, pain, disease progression, family suffering, and body image.
- Women's current life circumstances were often more salient than recurrence fears; triggers and coping strategies were also identified.
Conclusions:
- Further systematic research into women's breast cancer recurrence fears is warranted.
- Clinicians should acknowledge the multidimensional nature of these fears, considering individual life contexts and psychological processes.
- Tailoring social support interventions requires careful consideration of women's life circumstances to ensure efficacy.